Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) – Zenas BioPharma ZB020-03-002

Secondary Progressive MS Research Study – Join a Study Evaluating an Investigational Drug that Could Potentially Delay MS Disability Progression

Oakland Neurology Center, along with Profound Research, are enrolling a Multiple Sclerosis study that is assessing an investigational medication to see if it delays disability progression in adults with non-active Secondary Progressive Multiple Sclerosis. 

To be eligible to participate, you must: 

• Be 18-60 years of age 

• Have a previous diagnosis of Relapsing-Remitting Multiple Sclerosis (RRMS) and a current diagnosis of Secondary Progressive Multiple Sclerosis (SPMS) 

• Have disability progression without clinical relapses in the last 2 years 

• Have an expanded disability studies scale (EDSS) between 3.0-6.5 points 

Additional criteria apply. 

Qualified participants will receive: 

• Study-related care and study intervention at no cost 

• Financial compensation for time and reimbursement for travel expenses 

Number of visits and duration of study: 

• Number of clinic visits vary over a 60-month period, which includes a double-blind treatment period and an open-label treatment period. Double-blind means there is a chance you are assigned to take either the placebo comparator or the investigational study medication. Open-label means there will be no placebo comparator and everyone will receive the investigational study medication. 

Call us at 248-282-3640 or complete the form and our team will reach out soon to help determine your eligibility.